Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Bio Key International (BKYI) EBITDA (2016 - 2025)

Historic EBITDA for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to -$1.0 million.

  • Bio Key International's EBITDA fell 6004.89% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 1592.64%. This contributed to the annual value of -$4.3 million for FY2024, which is 4823.15% up from last year.
  • Per Bio Key International's latest filing, its EBITDA stood at -$1.0 million for Q3 2025, which was down 6004.89% from -$1.1 million recorded in Q2 2025.
  • Over the past 5 years, Bio Key International's EBITDA peaked at -$572560.0 during Q1 2024, and registered a low of -$6.8 million during Q4 2022.
  • Moreover, its 5-year median value for EBITDA was -$1.4 million (2024), whereas its average is -$1.7 million.
  • As far as peak fluctuations go, Bio Key International's EBITDA plummeted by 47825.09% in 2021, and later skyrocketed by 6714.66% in 2023.
  • Over the past 5 years, Bio Key International's EBITDA (Quarter) stood at -$2.0 million in 2021, then tumbled by 240.23% to -$6.8 million in 2022, then skyrocketed by 67.15% to -$2.2 million in 2023, then surged by 36.91% to -$1.4 million in 2024, then rose by 26.32% to -$1.0 million in 2025.
  • Its EBITDA was -$1.0 million in Q3 2025, compared to -$1.1 million in Q2 2025 and -$729742.0 in Q1 2025.